Ovarian Follicles Live or Die by a Molecular Tug-of-War, Mouse Study Finds

Every month, a mammalian ovary performs a brutal act of biological bookkeeping. Of the thousands of follicles that begin their development, only a tiny fraction will ever release an egg; in humans, as many as 95 percent of developing follicles are simply deleted. This wholesale elimination, known as follicular atresia, is not a disease but a fundamental quality-control program, one that determines which follicles survive to ovulate and which are dismantled and reabsorbed. Despite its central importance to fertility, the molecular logic that decides a follicle’s fate has remained only partially understood. Now, a study from researchers at Shandong First Medical University and Tsinghua University, published in the Journal of Ovarian Research, offers a new and unusually detailed picture of that decision-making machinery, revealing a delicate balance between two opposing signaling pathways inside the cells that nurse each developing egg.

The research, led by Ming Hao and Longping Liu under the corresponding authorship of Jianbin Wang, focuses on granulosa cells, the somatic cells that surround the oocyte and sustain its growth. Granulosa cell apoptosis, the team notes, initiates a considerable portion of follicular atresia, making these cells the natural place to look for the molecular switches of follicle death. The investigators’ earlier work had already identified the hypoxia-inducible factor 1 pathway, activated by follicle-stimulating hormone, as a protective factor that guards follicles against atresia. What remained unclear was precisely how that protection works, and how it interacts with the known pro-apoptotic forces inside the ovary.

To answer that question, the team adopted a methodological approach that sets the study apart from much of the existing literature. Rather than pooling many follicles together and averaging their molecular profiles, they employed a single-follicle, multi-dimensional profiling strategy based on serial sectioning. This allowed them to dissect the signaling logic underlying physiological follicle fate decisions follicle by follicle, preserving the spatial and individual variation that bulk analyses tend to erase. The technical toolkit behind the study included immunofluorescence, laser capture microdissection, and TUNEL labeling to detect apoptotic cells, alongside markers of oxidative stress such as 4-hydroxynonenal, 8-hydroxyguanosine, and 3-nitrotyrosine, which report lipid peroxidation, DNA oxidation, and protein nitration respectively.

The central finding is a striking complementarity. In the granulosa cells of healthy, growing mouse follicles, the HIF1 pathway is active, while in atretic follicles, those destined for destruction, it is the forkhead box protein O1 pathway that dominates. FOXO1 is a well-known transcription factor in the apoptosis field, capable of driving expression of pro-death genes including Bim, a member of the BH3-only family that pushes cells toward self-destruction. The observation that HIF1 and FOXO1 activation patterns are mutually exclusive across healthy and dying follicles suggests that the two pathways do not merely coexist in granulosa cells but actively compete to set the cell’s course.

Perhaps the most provocative element of the study concerns reactive oxygen species. ROS are often cast as villains in biology, the corrosive byproducts of metabolism that damage DNA, proteins, and membranes. Yet the researchers found that in growing mouse follicles, HIF1 pathway activity is associated with increased ROS-related signals, likely a consequence of enhanced granulosa-cell metabolic activity. Far from being a harbinger of doom, these ROS signals appear under physiological conditions to help maintain HIF1 pathway activity in granulosa cells during follicle growth. Crucially, the team reports that ROS-related signals are not by themselves associated with follicle atresia, a finding that complicates the simple oxidative-stress narrative and instead frames moderate ROS production as part of the metabolic engine that keeps a follicle alive and growing.

How, then, does HIF1 translate its activity into survival? The study’s answer lies in Bcl-XL, short for B-cell lymphoma-extra large, a canonical anti-apoptotic protein that works at the mitochondrial level to prevent the cascade of events leading to programmed cell death. The researchers present evidence that the HIF1 pathway appears to promote Bcl-XL expression in granulosa cells. This pro-survival output, they propose, may counterbalance the FOXO1-associated atretic pressure, the constant push toward apoptosis that FOXO1 and its downstream target Bim exert on the follicle. In other words, the follicle’s fate may hinge on which arm of this transcriptional contest wins control of the cell’s mitochondrial life-or-death machinery.

The authors synthesize these observations into a model of follicular fate as a dynamic balance between two axes: the pro-survival HIF1/Bcl-XL axis and the pro-apoptotic FOXO1/Bim axis. When HIF1 activity is sustained, supported in part by the ROS generated through active granulosa-cell metabolism, Bcl-XL expression holds the apoptotic machinery in check and the follicle continues to grow. When HIF1 activity wanes and FOXO1 takes over, Bim rises, Bcl-XL’s protective grip loosens, and the follicle slides into atresia. This framing transforms atresia from a passive failure into an active tug-of-war, one that can in principle be tipped in either direction by changes in hormonal signaling, metabolic state, or oxygen availability.

The experimental design reinforces the credibility of this model. The team used pregnant mare serum gonadotropin to stimulate follicle growth in mice and echinomycin, a pharmacological inhibitor of HIF1, to perturb the pathway experimentally, alongside N-acetyl-L-cysteine to modulate ROS levels. The use of Foxl2-CreER mice, obtained as a kind gift from Kui Liu’s laboratory at the University of Hong Kong Shenzhen Hospital, allowed granulosa-cell-specific manipulation. All animal experiments were approved by the Institutional Animal Care and Use Committee of Tsinghua University. The work was supported by the National Natural Science Foundation of China, and the authors declare no competing interests.

It is worth emphasizing what the study does and does not claim. The language of the paper is deliberately measured: HIF1 pathway activity is associated with Bcl-XL expression, and the balance model is presented as an association-based framework rather than a fully resolved causal chain. The findings are rooted in mouse ovaries, and while the conservation of HIF1, FOXO1, Bcl-XL, and Bim across mammals suggests the logic may generalize, direct evidence in human ovaries remains to be established. The authors themselves frame their conclusion as a description of what follicular fate appears to be associated with, a caution appropriate for a system as complex as the ovarian follicle, where endocrine, paracrine, and metabolic signals all converge.

Even with those caveats, the implications are considerable. Follicular atresia sits at the heart of some of the most consequential questions in reproductive biology: how the ovarian reserve is spent over a lifetime, why some follicles are selected while others are discarded, and how conditions such as polycystic ovary syndrome, a subject the journal explicitly links to this work, disrupt follicle selection. A clearer mechanistic understanding of the HIF1/Bcl-XL and FOXO1/Bim axes provides researchers with a defined set of molecular levers to investigate in these contexts. If the balance identified in mouse ovaries proves relevant to human follicle dynamics, it could eventually inform strategies aimed at preserving ovarian function, improving assisted reproduction outcomes, or extending fertility. For now, the study stands as a vivid demonstration that a follicle’s survival is not a matter of chance but of a measurable, contestable molecular equilibrium, one that science is only beginning to read in full.

Subject of Research: The molecular regulation of ovarian follicle atresia by the opposing HIF1/Bcl-XL survival and FOXO1/Bim apoptotic signaling axes in mouse granulosa cells

Article Title: HIF1 counteracts FOXO1/Bim-associated follicle atresia in mouse ovaries by promoting Bcl-XL expression

Article References: Hao, M., Liu, L., & Wang, J. (2026). HIF1 counteracts FOXO1/Bim-associated follicle atresia in mouse ovaries by promoting Bcl-XL expression. Journal of Ovarian Research. https://doi.org/10.1186/s13048-026-02284-7

Image Credits: AI Generated

DOI: 10.1186/s13048-026-02284-7

Keywords: follicle atresia, granulosa cells, HIF1 pathway, FOXO1, Bcl-XL, Bim, apoptosis, reactive oxygen species, ovarian follicles, fertility, follicle selection, Journal of Ovarian Research